Taro Pharmaceutical Industries Ltd.
TARO
TARO was delisted on the 21st of June, 2024.
76 hedge funds and large institutions have $342M invested in Taro Pharmaceutical Industries Ltd. in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 31 reducing their positions, and 11 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
4% less capital invested
Capital invested by funds: $357M → $342M (-$15.6M)
5% less funds holding
Funds holding: 80 → 76 (-4)
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
39% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$7.34M |
| 2 |
Morgan Stanley
New York
|
+$2.5M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.44M |
| 4 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$1.35M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$1.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIP
Brandes Investment Partners
La Jolla,
California
|
-$11.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.88M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.61M |
| 4 |
Citigroup
New York
|
-$1.57M |
| 5 |
EF
Empirical Finance
Havertown,
Pennsylvania
|
-$1.39M |
TARO Hedge Fund Activity: Q2 2021 in Review
76 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q2 2021, worth a combined $342M — down 4.4% from $357M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of TARO and 7 opened new positions — a net loss of 4 holders — while 31 trimmed existing stakes and 19 added.
The largest buyer was Ameriprise, adding an estimated $7.34M. The largest seller was Brandes Investment Partners, cutting an estimated $11.1M.
- 76 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q2 2021, down from 80 in Q1 2021.
- Funds reported $342M of Taro Pharmaceutical Industries Ltd. stock for Q2 2021, down 4.4% quarter-over-quarter.
- 7 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q2 2021 and 11 closed out, a net change of -4 holders.
- The largest Taro Pharmaceutical Industries Ltd. buyer in Q2 2021 was Ameriprise, an estimated $7.34M added.
- The largest Taro Pharmaceutical Industries Ltd. seller in Q2 2021 was Brandes Investment Partners, an estimated $11.1M sold.
Based on aggregated 13F filings for Q2 2021.